BBS7 anticorps (AA 263-510)
Aperçu rapide pour BBS7 anticorps (AA 263-510) (ABIN1886284)
Antigène
Voir toutes BBS7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 263-510
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 263 and 510 of Human BBS7
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- BBS7 (Bardet-Biedl Syndrome 7 (BBS7))
-
Autre désignation
- BBS7
-
Sujet
-
Mutations in this gene have been observed in patients with Bardet-Biedl syndrome type 7.The encoded protein may play a role in eye, limb, cardiac and reproductive system development.Two transcript variants encoding distinct isoforms have been identified for this gene.[provided by RefSeq]
-
Poids moléculaire
- 80 kDa
-
ID gène
- 55212
-
NCBI Accession
- NP_789794, NM_176824
-
Pathways
- Signalisation Hedgehog
Antigène
-